Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcb004f4cdc56d81da7e896b2e1d8eb6 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-708 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-708 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-207 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-20 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-20 |
filingDate |
2013-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e98192afc08ebd87bb40c7ab3722fcf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e6022f1594b3d6879a5583d92520006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de1971f6784ae952d33195770c9014bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bc2ad7ebb6a1ab5183efd3dd5aa9ad4 |
publicationDate |
2014-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CL-2013003487-A1 |
titleOfInvention |
Use of a compound derived from nucleoside phosphoramidate to treat dengue fever and specific compounds. |
abstract |
THIS APPLICATION PROVIDES THE USE OF A NUCLOSED PHOSPHORAMIDATE DERIVATIVE COMPOSITE TO TREAT FEVER DENGUE. IN ADDITION, SPECIFIC COMPOUNDS DERIVED FROM NUCLOSIDE PHOSPHORAMIDATE ARE DESCRIBED. |
priorityDate |
2011-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |